Impact of Arterial Thrombotic Events on the Outcome of Chronic Myeloid Leukemia Patients Treated with Nilotinib First-Line: A GIMEMA CML WP Analysis

Nilotinib has shown better efficacy compared to imatinib, but it has been associated to a higher incidence of arterial thrombotic events (ATEs).

Source: Clinical Lymphoma, Myeloma and Leukemia - September 1, 2017 Category: Hematology Authors: Gabriele Gugliotta, Fausto Castagnetti, Massimo Breccia, Mariella D'Adda, Fabio Stagno, Luciano Levato, Angelo Michele Carella, Bruno Martino, Mario Tiribelli, Giovanna Rege-Cambrin, Antonella Gozzini, Marzia Salvucci, Michele Cedrone, Elena Trabacchi, Em Source Type: research